Skip to main content
SoftOx Solutions AS logo

SoftOx Solutions AS — Investor Relations & Filings

Ticker · SOFTX ISIN · NO0010811961 LEI · 549300AETMWJS91G4A50 OL Manufacturing
Open in API
Filings indexed 574 across all filing types
Latest filing 2018-12-21 Share Issue/Capital Cha…
Country NO Norway
Listing OL SOFTX

About SoftOx Solutions AS

https://soft-ox.com/

SoftOx Solutions AS is a clinical-stage pharmaceutical company that has developed a patented, non-toxic antimicrobial technology. The technology is based on a stabilized formulation of hypochlorous acid (HOCl), an endogenous molecule used by the human immune system to combat pathogens. It is designed to be highly effective against a broad spectrum of bacteria, viruses, and fungi, and to eradicate and prevent biofilm infections. A key feature of the technology is that its mode of action does not induce antimicrobial resistance (AMR). The company's development pipeline focuses on significant health challenges, with a lead candidate, SoftOx Inhalation Solution (SIS), for treating airway infections, as well as other applications in wound care and disinfection.

Recent filings

Filing Released Lang Actions
Successful private placement
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces the 'Successful private placement' of new shares, detailing the amount raised (NOK 15 million), the number of shares (680,000), the subscription price (NOK 22), and mentions the involvement of primary insiders receiving allocations. This activity directly relates to fundraising, capital structure changes, and the issuance of new shares. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). While it involves share issuance (SHA), the primary focus and context is the successful completion of a financing round (Private Placement), making CAP the most precise classification.
2018-12-21 English
SoftOx Solutions AS - Contemplated private placement
Share Issue/Capital Change Classification · 99% confidence The document explicitly discusses a 'Contemplated private placement' of new shares to raise capital (NOK 15 million). It details the offer price, subscription period, use of proceeds (funding clinical trials), and mentions that the completion is subject to corporate resolutions, potentially including an extraordinary general meeting. This content directly relates to fundraising, financing activities, and changes in capital structure. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (2805 chars) is substantial enough to be the primary announcement, not just a notice of publication (RPA).
2018-12-14 English
SoftOx Solutions AS - 3rd. quarter report 2018
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Report 3rd quarter 2018' and contains comprehensive financial statements (Profit and Loss, Balance Sheet, Cash Flow, and Statement of Equity) for the SoftOx Solutions Group. It includes an operational review, management commentary, and notes to the financial statements. As it covers a period shorter than a full fiscal year and provides substantive financial data, it is classified as an Interim/Quarterly Report. 9M 2018
2018-12-11 Norwegian
SoftOx Solutions AS - 3rd. quarter report 2018
Report Publication Announcement Classification · 100% confidence The document is extremely short (158 characters) and explicitly states 'Attached is SoftOx Solutions AS - 3rd. quarter report 2018'. According to the 'MENU VS MEAL' rule, a document that announces the availability of a report rather than containing the substantive financial data itself is classified as a Report Publication Announcement (RPA). Q3 2018
2018-12-11 English
Financial calendar
Report Publication Announcement Classification · 99% confidence The document text is titled 'Financial calendar' and lists expected publication dates for various reports like 'Annual Report', 'Quarterly Report', and 'Half-yearly Report' for fiscal years 2018 and 2019. It is not the report itself, but rather an announcement detailing *when* reports will be released. This fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports.
2018-12-09 English
SOFTOX AND ANTIBAC ENTERS INTO NEGOTIATIONS ON EXCLUSIVE DEVELOPMENT AND DISTRIBUTION FOR NEW LINE OF ANTISEPTIC PRODUCTS BASED ON THE NEW INNOVATIVE TECHNOLOGY DEVELOPED BY SOFTOX
Regulatory Filings Classification · 95% confidence The document text describes negotiations between two companies (SoftOx Solutions AS and Antibac AS) regarding an exclusive development and distribution agreement for a new line of antiseptic products. This type of announcement, detailing strategic business development, partnership negotiations, and potential future commercial agreements, does not fit neatly into standard financial reporting categories like 10-K, ER, or IR. It is a significant corporate event announcement. Since there is no specific category for 'Partnership/M&A Negotiation' other than TAR (M&A Activity), and this is more about a strategic commercial deal than a takeover bid, the most appropriate general category for a significant, non-standard corporate announcement is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory disclosures that impact the market.
2018-11-02 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.